• <ul id="qe0qg"></ul>
    <ul id="qe0qg"><sup id="qe0qg"></sup></ul>
  • <fieldset id="qe0qg"><menu id="qe0qg"></menu></fieldset>
  • <strike id="qe0qg"></strike>
  • <ul id="qe0qg"></ul>
    <strike id="qe0qg"></strike>
    豪森藥業(yè)
    • Overview
    • 1995 Initial establishment
      A principal subsidiary of Hansoh Pharma (03692.HK)
      7
      Launched innovative drugs
      Top 100
      Pharmaceutical companies worldwide
      Top 3
      China's best Industrial enterprises in pharmaceutical R&D pipeline

    Therapy Areas

    • Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      We focus on the develoment of new drugs in the field of common and hostile cancers.Our innovative medicine programs in clinical trials include HS-20106 injection, HS-20105 injection, HS-20117 injection, HS-10516 capsules, HS-10382 tablets, HS-10370 tablets, HS-10502 tablets, HS-10365 capsules, HS-20089 injection, HS-20093 injection, HS-10352 tablets, HS-10241 tablets, etc.
      More +
    • Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      We focus on the development of new drugs in the fields of antiviral, anti-complex bacterial infection and anti-fungal infection. Our innovative medicine programs in clinical trials includeCitric Acid Erythorbate tablets, etc.
      More +
    • CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      We focus on the development of new drugs in the fields of psychiatric and neurological disorders.Our innovative medicine programs in clinical trials include HS-10380 tablets, HS-10506 tablets, HS-10353 capsules, HS-10509 tablets, etc.
      More +
    • Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      We focus on the development of new drugs in the field of metabolic diseases such as diabetes and obesity. Our innovative medicine programs in clinical trials include HS-10511 tablets, HS-20094 injection, HS-10384 tablets, HS-10518 capsules, HS-10390 tablets, HS-10501 tablets, and HS-10398 capsules, etc.
      More +
    • Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      We focus on the development of new drugs in the field of autoimmune diseases. Our innovative medicine programs in clinical trials includeHS-10374 tablets etc.
      More +
    R&D
    Innovation
    Jiangsu Hansoh Pharma Research Institute
    Jiangsu Hansoh Pharma Research Institute
    More
    Jiangsu Hansoh Pharma Administrative R&D Center
    Jiangsu Hansoh Pharma Administrative R&D Center
    More
    • Substantial investment on R&D
      In 2024, R&D expenditure was RMB2,702 million, and accounted for 22.0% of the revenue.
    • Competitive R&D pipeline
      More than 60 clinical trials of innovative drug candidates being investigated, covering 40 innovative drug candidates.
    • Highly efficient capability to discover innovative drugs
      The R&D pipeline covers peptides , small molecules, biologics, ADC drugs, siRNAs, and more.
    A broader world, let's discover together
    Join Hansoh Pharma +
    Work with us
    We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
    Join Hansoh Pharma +
    主站蜘蛛池模板: 久久精品国产一区二区三区不卡 | 亚洲国产精品特色大片观看完整版| 亚洲国产精品一区二区第一页| 成人国产精品动漫欧美一区| 国产成人精品无码播放| 色偷偷88欧美精品久久久| 911亚洲精品不卡| 久久久无码人妻精品无码| 欧洲精品一区二区三区在线观看| 97精品国产高清自在线看超| 99久久99这里只有免费的精品| 亚洲国产精品无码专区| 欧美亚洲精品中文字幕乱码免费高清| 秋霞久久国产精品电影院| 97久久超碰国产精品2021| 日产精品一线二线三线芒果| 亚洲国产精品毛片av不卡在线| 国产成人综合精品一区| 国内精品在线视频| 国产久热精品无码激情| 亚洲第一极品精品无码久久| 亚洲精品动漫免费二区| 男人的天堂精品国产一区| 国产乱人伦精品一区二区在线观看 | 久久精品国产亚洲精品| 国产精品 一区 在线| 一本一道久久精品综合| 国产精品久久久久aaaa| 99久久婷婷免费国产综合精品| 国产亚洲精品自在久久| 久久精品人成免费| 日韩精品无码一区二区三区免费 | 久久国产精品偷99| 国产精品亚洲专区无码WEB | 久久精品九九亚洲精品| 亚洲国产另类久久久精品小说 | 精品亚洲成α人无码成α在线观看| 99re66在线观看精品免费| 青青草国产精品久久| 亚洲国产精品成| 国产成人精品综合在线观看|